In reply to the Letter to the Editor by Chen and Lui regarding 'Radiotherapy enhances uptake and efficacy of 90 Y-cetuximab: A preclinical trial' by A Dietrich et al

Autor: Dietrich, A., Andreeff, M., Koi, L., Bergmann, R., Schubert, M., Schreiner, L., Löck, S., Sihver, W., Freudenberg, R., Hering, S., Pietzsch, H.-J., Steinbach, J., Kotzerke, J., Baumann, M., Krause, M.

Publikováno v: Radiotherapy and Oncology 161(2021), 261-262

It is the reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of 90 Y-cetuximab: A preclinical trial" by A Dietrich et al. Abstract: Background and purpose: Systemic molecular radiotherapy utilizes i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4577::a31fc5dff5b389b7992794dacac2ce9b
https://www.hzdr.de/publications/Publ-33958-1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Kombinierte externe und interne Bestrahlung von Tumoren: präklinischer Nachweis des kurativen Potenzials

Autor: Pietzsch, H.-J., Dietrich, A., Andreeff, M., Koi, L., Schreiner, L., Bergmann, R., Löck, S., Sihver, W., Faulhaber, D., Kotzerke, J., Baumann, M., Krause, M., Steinbach, J.

Publikováno v: Wissenschaftsforum Chemie, 10.-14.09.2017, Berlin, Deutschland

Die Therapie von Tumorerkrankungen gründet sich stadienabhängig auf die drei Säulen Chirurgie, Strahlen- und Chemotherapie. Grundprinzip der Strahlentherapie ist die gezielte Einwirkung von ionisierender Strahlung auf erkranktes Gewebe, um die Zer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4577::f189bb92fbc1937dd37b47ace9c21700
https://www.hzdr.de/publications/Publ-25777-1

Combination of 90Y-labelled-Cetuximab with fractionated radiotherapy: report on therapy scheduling and curative potential

Autor: Dietrich, A., Andreeff, M., Koi, L., Schubert, M., Sihver, W., Faulhaber, D., Pietzsch, H.-J., Steinbach, J., Kotzerke, J., Baumann, M., Krause, M.

Publikováno v: 22nd International Symposium on Radiopharmaceutical Sciences, 14.-19.05.2017, Dresden, DeutschlandJournal of Labelled Compounds and Radiopharmaceuticals

External beam irradiation (EBRT) can precisely target solid tumors but is limited by the surrounding normal tissue. Radioimmunotherapy mediates additional internal irradiation with the potential to strike also (micro-)metastases. The combination of i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4577::8f6e6f2537ac778e3ec1bc8fbf4b9576
https://www.hzdr.de/publications/Publ-24345-1

The Role of epithelial to mesenchymal transition (EMT) as Biomarker for Radioresistance in HNSCC

Autor: Kurth, I., Digomann, D., Hein, L., Linge, A., Koi, L., Loeck, S., Maebert, K., Stephan, H., Peitzsch, C., Krause, M., Baumann, M., Dubrovska, A.

Publikováno v: Radiotherapy and Oncology 123(2017), S534-S535

Purpose or Objective It is described that epithelial – to -mesenchymal transition (EMT) plays an important role in head and neck squamous carcinomas (HNSCC) progression and resistance to therapy. Recent studies suggest that for instance the express

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4577::5111c76acc50ae9b554c7fb57191628e
https://www.hzdr.de/publications/Publ-26992-1